Liu, Y., Huang, Z., Gong, L., Zhang, Z., Zhang, S., & Zhou, Y. (2020). N-terminal pro-brain natriuretic peptide used for screening hemodynamically significant patent ductus arteriosus in very low birth weight infants: How and when? Clinical Hemorheology & Microcirculation, 75(3), 335. https://doi.org/10.3233/CH-190803
Chicago Style (17th ed.) CitationLiu, Ying, Zhen-Li Huang, Lin Gong, Zhen Zhang, Shuang-Chuan Zhang, and Yu-Xin Zhou. "N-terminal Pro-brain Natriuretic Peptide Used for Screening Hemodynamically Significant Patent Ductus Arteriosus in Very Low Birth Weight Infants: How and When?" Clinical Hemorheology & Microcirculation 75, no. 3 (2020): 335. https://doi.org/10.3233/CH-190803.
MLA (9th ed.) CitationLiu, Ying, et al. "N-terminal Pro-brain Natriuretic Peptide Used for Screening Hemodynamically Significant Patent Ductus Arteriosus in Very Low Birth Weight Infants: How and When?" Clinical Hemorheology & Microcirculation, vol. 75, no. 3, 2020, p. 335, https://doi.org/10.3233/CH-190803.